Prolight Diagnostics
20.80 SEK
-0.48 %
Less than 1K followers
PRLD
Nordic SME
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-0.48 %
-5.88 %
-6.73 %
-4.59 %
+69.58 %
+64.67 %
+22.83 %
-89.18 %
-47.15 %
Prolight Diagnostics develops point-of-care (POC) systems. These are small mobile instruments with disposable test cards that can perform In-Vitro Diagnostic (IVD) tests from a drop of blood. The POC system can contribute to faster and more accurate diagnoses of acute conditions. The company's launch product will be a highly sensitive measurement of troponin to be able to determine and exclude heart attacks.
Read moreMarket cap
250.53M SEK
Turnover
156.63K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26/2
2026
Annual report '25
26/5
2026
Interim report Q1'26
26/5
2026
General meeting '26
All
Webcasts
Press releases
3rd party
ShowingAll content types
Biostock publishes an article about the key milestone toward commercialisation - assay design freeze
BioStock: Prolight Diagnostics når assay design freeze för det högkänsliga troponintestet – en avgörande milstolpe för Psyros
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools